During the past decade, The Ottawa Hospital, Riverside Campus conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Ottawa Hospital, Riverside Campus" #1 sponsor was "Bayer" with 5 trials, followed by "Ottawa Hospital Research Institute" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Celgene" with 1 trials sponsored and "Kowa Research Institute, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Ottawa Hospital, Riverside Campus" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Heart and Stroke Foundation of Ontario" with 1 trials as a collaborator and "Ottawa Hospital Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "The Ottawa Hospital, Riverside Campus" are "Hot Flashes" (2 trials), "Vasomotor Symptoms Associated With Menopause" (2 trials), "Aortic Aneurysm, Abdominal" (1 trials), "Atrial Fibrillation" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "The Ottawa Hospital, Riverside Campus" in a lesser frequency.

Most popular intervention types in "The Ottawa Hospital, Riverside Campus" are "Drug" (14 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Elinzanetant (BAY3427080)" (2 trials), "Vilaprisan (BAY1002670)" (2 trials), "Adrenocorticotrophic hormone" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Ottawa Hospital, Riverside Campus" are 11 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "The Ottawa Hospital, Riverside Campus". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in The Ottawa Hospital, Riverside Campus, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in The Ottawa Hospital, Riverside Campus, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".